Bridgeway Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-29,100
Closed -$4.5M – 1365
2021
Q4
$4.5M Hold
29,100
– – 0.08% 365
2021
Q3
$4.94M Hold
29,100
– – 0.09% 325
2021
Q2
$4.59M Sell
29,100
-100
-0.3% -$14.9K 0.08% 340
2021
Q1
$4.05M Hold
29,200
– – 0.08% 340
2020
Q4
$5.11M Hold
29,200
– – 0.11% 243
2020
Q3
$5.71M Buy
29,200
+9,500
+48% +$1.59M 0.13% 181
2020
Q2
$3.35M Buy
19,700
+1,000
+5% +$149K 0.07% 272
2020
Q1
$2.16M Buy
+18,700
New +$2.07M 0.05% 317

Other funds holding SGEN

Bridgeway Capital Management's SGEN Position: Q1 2022 in Review

Bridgeway Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q1 2022, closing a stake of 29,100 shares — an estimated $4.5M sold.

Bridgeway Capital Management first reported a position in SGEN in Q1 2020 and held it in 8 quarters. The position peaked at $5.71M in Q3 2020. 505 funds tracked by Wall St. Rank hold SGEN as of Q1 2022.

  • Bridgeway Capital Management reported no remaining Seagen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 29,100 Seagen Inc. Common Stock shares in Q1 2022, an estimated $4.5M.
  • Bridgeway Capital Management first reported a position in Seagen Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • Bridgeway Capital Management's Seagen Inc. Common Stock position peaked at $5.71M in Q3 2020.
  • 505 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2022.

Based on Bridgeway Capital Management's 13F filing for Q1 2022, filed 16 May 2022.